ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : MedImmune, Inc.

Include trials that are no longer recruiting patients.

3 studies were found.
1.RecruitingMEDI-522 in the Treatment of Patients with Metastatic Androgen-Independent Prostate Cancer
Condition: Prostate Cancer
2.RecruitingStudy Evaluating Whether The Addition Of Amifostine (Ethyol®) Will Enable The Safe Increase In Dose Intensity Of Idarubicin In Combination With Cytosine Arabinoside In Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia; Acute Myeloid Leukemia
3.RecruitingSubcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients with Unresectable Non-Small Cell Lung Cancer
Conditions: Esophagitis; Pneumonitis; Non-small cell lung cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act